United States News Todas as matérias

The Coca-Cola Company (NYSE:KO) reported third-quarter 2026 revenue of $13.4 billion, up 7% year over year, while adjusted earnings rose 11% to $0.91 per share, exceeding analysts’ $0.88 consensus estimate.

UPS (NYSE:UPS) reported third-quarter 2026 revenue of $22.9 billion, up 6.7% year over year, as growth across all business segments supported higher financial guidance.

Hycroft Mining Holding Corporation (NASDAQ:HYMC) reported $211 million in unrestricted cash and no debt in its third-quarter update, supporting continued exploration and development work at its Hycroft mining project.

AllianceBernstein Holding (NYSE:AB) reported third-quarter 2026 adjusted earnings of $0.88 per unit, up 2.3% year over year, as net revenues increased 7.8% to $1.226 billion.

Ares Capital (NASDAQ:ARCC) declared a fourth-quarter dividend of $0.48 per share as third-quarter GAAP net income fell to $319 million from $404 million a year earlier.

Daqo New Energy (NYSE:DQ) reported third-quarter 2026 revenue of $194.2 million as polysilicon shipments increased, narrowing its net loss to $52.9 million from $81.2 million in the previous quarter.

Smithfield Foods (NASDAQ:SFD) reported fiscal third-quarter operating profit of $127 million, down from $310 million a year earlier, as sales fell 8.3% to $3.4 billion for the quarter ended September 27, 2026.

Cementos Pacasmayo (NYSE:CPAC) reported third-quarter 2026 EBITDA of S/233.1 million, up 45.1% from the same quarter in 2025, as revenue and sales volumes increased.

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) received European Union approval for Enhertu as an adjuvant treatment for eligible adults with HER2-positive early breast cancer and residual invasive disease after neoadjuvant treatment.

NVIDIA (NASDAQ:NVDA) plans to invest $3 billion in Meta’s equity offering as the companies expand their collaboration on AI models, computing infrastructure and agent development.

Pharming Group (NASDAQ:PHAR) reported preliminary third-quarter 2026 revenue of $117.6 million, up 21% year over year, as operating profit rose 89% to $29.9 million.

Innate Pharma (NASDAQ:IPHA) announced that high-level data from the PACIFIC-9 Phase 3 trial are now expected in the first half of 2027, following a timeline revision by AstraZeneca (NYSE:AZN).

TechTarget (NASDAQ:TTGT), operating as Informa TechTarget, reported underlying revenue growth of -1.6% for the nine months ended September 30, 2026, as technology customers shifted spending priorities toward artificial intelligence.

CoreWeave (NASDAQ:CRWV) has expanded its global AI infrastructure by bringing most of its planned 22.5 megawatts of IT capacity online in Denmark and extending its network into the Middle East and Asia Pacific.

Cellectis (NASDAQ:CLLS) presented preclinical data for HEAL-101, a gene-editing candidate for severe hypertriglyceridemia, reporting approximately 90% mean editing in human liver cells.

Eli Lilly and Company (NYSE:LLY) declared a fourth-quarter 2026 cash dividend of $1.73 per share on its outstanding common stock, continuing shareholder distributions through the end of the year.

Gildan Activewear (NYSE:GIL) announced on October 26, 2026, that it completed the sale of HanesBrands Australia to BBFIT Investments Pte Ltd for approximately A$700 million, equivalent to US$490 million, paid entirely in cash at closing.

Cemex (NYSE:CX) reported third-quarter 2026 revenue of $4.59 billion, an increase of 8% from $4.25 billion a year earlier, surpassing Wall Street's consensus estimate of $4.45 billion.

MakeMyTrip Limited (NASDAQ:MMYT) reported fiscal second-quarter 2027 revenue of $235.2 million, an increase of 2.5% year over year, although the figure fell short of analysts' expectations of approximately $267.4 million to $269.1 million.

Citizens Community Bancorp (NASDAQ:CZWI) reported third-quarter 2026 net income of $5.4 million, compared with $1.1 million in the preceding quarter and $3.7 million a year earlier, while diluted earnings reached $0.56 per share.

XTEND AI Robotics (NYSE:XTND) announced preliminary, unaudited financial results projecting total revenue of $24.5 million to $26.5 million for the nine months ended September 30, 2026, exceeding its full-year 2025 revenue.

Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, a 19.4% decline from $89.4 million a year earlier, while its net loss widened to $17.5 million, or $1.57 per share, from $2.3 million, or $0.21 per share.

Lakeland Financial Corporation (NASDAQ:LKFN) reported record third-quarter 2026 net income of $28.9 million, an increase of 9% from $26.4 million a year earlier, while diluted earnings per share rose 11% to $1.14.

Sierra Bancorp (NASDAQ:BSRR) reported record third-quarter 2026 net income of $15.3 million, a 58% increase from $9.7 million a year earlier, while diluted earnings per share climbed 64% to $1.18 from $0.72.